Today’s top gainers include the company Gilead Sciences Inc. (NASDAQ:GILD) which is in the industry Biotechnology, gaining 0.81% today. In the last week its performance is -1.81%, and -6.57% for the past quarter. Currently, Gilead Sciences Inc., GILD has a target price of 106.35, so today’s gain of 0.81% is a significant step towards its target price. The GAP today is therefore 0.54%.
Gilead Sciences Inc. (NASDAQ:GILD), has a market cap of 108605.26, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 81.70%.
At the current price of 80.42, it has a dividend yield of 2.36%, and its target price is 106.35. This is with a profit margin of 50.50%, and total debt/equity of 0. Gilead Sciences Inc. (NASDAQ:GILD) has a P/E of 7.03, as well as a forward P/E of 6.79.
With a current EPS of 11.35, and a forecasted EPS growth for next year at -0.25%,Gilead Sciences Inc. (NASDAQ:GILD) has had a EPS growth for the past five years at 48.30%. For the next five years EPS growth is projected to be 0.08%.
Performance for the year is -31.51%. Since its IPO date on 1/22/1992, the total performance to date is -20.34%.
Volume today for Gilead Sciences Inc. (NASDAQ:GILD), is 3790149, while its average volume is 10037.22. Whilst the total gain today was 0.81%, it did have a day high of -9.49%.
Volatility for this week has been at 1.78%, and 1.85% for the month. The 52-week low for Gilead Sciences Inc., GILD has been 3.21%, while the 52-week-high has reached -31.76%.
Looking at its return of investments, which is 45.90%, and its return on assets is 32.70%. Gilead Sciences Inc. (NASDAQ:GILD) has an operating margin of 63.00%. With a sales growth of -5.70% quarter over quarter. Bearing in mind that Gilead Sciences Inc., GILD is in the sector Healthcare, its long-term debt/equity is 0, and has a current ratio of 3.1 and 2.9 for quick ratio.
So what is the value of Gilead Sciences Inc.? Well its PEG is 87.83, and the P/S is 3.36, along with a P/B of 6.61. Meanwhile it has a p/cash of *TBA.